CALTON & ASSOCIATES, INC. - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 179 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.

Quarter-by-quarter ownership
CALTON & ASSOCIATES, INC. ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$113,848
-3.0%
22,907
-3.6%
0.05%
-1.9%
Q1 2023$117,382
+14.4%
23,761
+45.6%
0.05%
+35.0%
Q4 2022$102,616
-16.6%
16,314
+42.3%
0.04%
-42.9%
Q3 2022$123,000
-37.6%
11,468
-33.9%
0.07%
-35.8%
Q2 2022$197,000
+18.7%
17,352
-5.3%
0.11%
+122.4%
Q1 2022$166,000
-32.2%
18,329
+92.0%
0.05%
-9.3%
Q3 2021$245,000
+14.5%
9,546
+57.3%
0.05%
+28.6%
Q1 2021$214,0006,0670.04%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders